Atıf Formatları
Factors affecting disease-free survival in patients with human epidermal growth factor receptor 2-positive breast cancer who receive adjuvant trastuzumab.
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

S. Gündüz Et Al. , "Factors affecting disease-free survival in patients with human epidermal growth factor receptor 2-positive breast cancer who receive adjuvant trastuzumab.," Molecular and clinical oncology , vol.3, pp.1109-1112, 2015

Gündüz, S. Et Al. 2015. Factors affecting disease-free survival in patients with human epidermal growth factor receptor 2-positive breast cancer who receive adjuvant trastuzumab.. Molecular and clinical oncology , vol.3 , 1109-1112.

Gündüz, S., Göksu, S., Arslan, D., Tatli, A. M., Uysal, M., Gündüz, U. R., ... Sevinç, M. M.(2015). Factors affecting disease-free survival in patients with human epidermal growth factor receptor 2-positive breast cancer who receive adjuvant trastuzumab.. Molecular and clinical oncology , vol.3, 1109-1112.

Gündüz, ŞEYDA Et Al. "Factors affecting disease-free survival in patients with human epidermal growth factor receptor 2-positive breast cancer who receive adjuvant trastuzumab.," Molecular and clinical oncology , vol.3, 1109-1112, 2015

Gündüz, ŞEYDA Et Al. "Factors affecting disease-free survival in patients with human epidermal growth factor receptor 2-positive breast cancer who receive adjuvant trastuzumab.." Molecular and clinical oncology , vol.3, pp.1109-1112, 2015

Gündüz, S. Et Al. (2015) . "Factors affecting disease-free survival in patients with human epidermal growth factor receptor 2-positive breast cancer who receive adjuvant trastuzumab.." Molecular and clinical oncology , vol.3, pp.1109-1112.

@article{article, author={ŞEYDA GÜNDÜZ Et Al. }, title={Factors affecting disease-free survival in patients with human epidermal growth factor receptor 2-positive breast cancer who receive adjuvant trastuzumab.}, journal={Molecular and clinical oncology}, year=2015, pages={1109-1112} }